Ropes & Gray has advised Sanofi, and Cooley has advised MapLight Therapeutics on the transaction. MapLight Therapeutics, a biotechnology company focused on developing therapeutics for central...
MapLight Therapeutics’ $372.5 Million Series D Financing
Avant’s $250 Million Financing from Ares
Cooley advised Avant on the deal. Avant, a credit-first financial technology company, announced that it secured $250 million of corporate debt and redeemable preferred equity from...
Chingona Ventures’ $52 Million Fund Closing
Cooley advised Chingona Ventures on the deal. Chingona Ventures, a venture capital firm that invests in founders whose backgrounds uniquely position them to create businesses in...
Kriya Therapeutics’ $270 Million Series C Financing Round
Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing...
Veho’s $170 Million Series B Financing Round
Cooley advised Veho on the deal. Veho, a technology-driven logistics company, announced its $170 million Series B, which brings the company’s valuation to more than $1.5...
Freshworks’ $1.13 Billion IPO
Orrick Herrington & Sutcliffe advised the underwriters on the deal while Cooley advised Freshworks. Freshworks Inc., a software-as-a-service (SaaS) company, announced its initial public offering of 28,500,000...
G2.com’s $157 Million Series D Financing Round
Cooley LLP advised G2.com on the deal. G2.com, a software review site, announced its $157 million Series D financing round, which brings its valuation to $1.1 billion....
Amount’s $100 Million Series D Financing Round
Cooley LLP advised Amount on the deal. Amount, a technology provider for financial institutions, announced its nearly $100 million Series D financing round, which brings its valuation...